Combinatorial Screening for the Detection of Weak Interactions
J = 6.4 Hz, 6 H, NCH2), 4.21 (dt, J = 1.3, 6.4 Hz, 6 H, NCH2), 112.63, 67.92, 56.21, 55.87, 54.66 ppm. MS (ESI, MeOH): calcd.
8.90 (t, J = 1.3 Hz, 3 H, CH=N) ppm. C30H57Cl3N6 (608.18): calcd. for [M]+ 221.2, found 221.0. C13H21ClN2O (256.77): calcd. C 60.81,
C 59.25, H 9.45, N 13.82; found C 59.01, H 9.52, N 13.71.
H 8.24, N 10.91; found C 60.95, H 8.19, N 11.02.
2-tert-Butyl-6-formylphenyl Ethylphosphonate (P4): A solution of 2-
tert-butyl-6-formylphenol in dry THF (1.01 g, 5.61 mmol) was
slowly added to a suspension of NaH (11.2 mmol) under N2 at
0 °C. Immediately afterwards, ethylphosphonic dichloride (1.65 g,
11.2 mmol) was added and the solution allowed to warm to room
temperature. After 12 h, it was cooled again to 0 °C, and 12 HCl
(2 mL) was added, which resulted in the immediate precipitation
of a white solid. After filtration, the THF was evaporated and the
crude product taken up with chloroform and extracted first with a
pH = 8 aqueous solution of NaHCO3 and next with a pH = 1
solution of HCl. After drying, evaporation of the organic solvent
gave 624 mg of a greenish-yellow solid. This material was triturated
with ethanol and dried to give a white solid (590 mg). The above
acid (40.4 mg, 0.15 mmol) was converted into the tetrabutylammo-
nium salt by dissolving it in methanol and adding tetrabutylammo-
nium acetate (45.1 mg, 0.15 mmol) dissolved in water. The meth-
anol was evaporated, and the residual water was removed by lyoph-
ilization. A white solid (79 mg) was obtained. 1H NMR (250 MHz,
CD3OD): δ = 10.51 (s, 1 H, CHO), 7.65 (m, 3 H, Ar), 3.24 (m, 8
H, NCH2), 1.9–1.7 (m, 2 H, PCH2), 1.7–1.6 (m 8 H, CH2), 1.6–1.4
P3C: 1H NMR (300 MHz, CD3OD): δ = 8.76 (s, 1 H, CH=N),
7.90 (dd, J = 7.71, 1.74 Hz, 1 H, Ar), 7.4 (m, 1 H, Ar), 7.15–7.34
(m, 5 H, Ar), 6.82–6.93 (m, 2 H, Ar), 4.62 (s, 2 H, CH2Ar), 3.68
(s, 3 H, OCH3) ppm. 13C NMR (50 MHz, CD3OD): δ = 162.05,
141.68, 136.77, 134.21, 129.58, 129.35, 128.09, 125.00, 123.10,
121.79, 112.63, 56.35, 55.70 ppm. MS (ESI, CH3CN + 0.1%
HCOOH): calcd. for [M + H]+ 226.2, found 226.0. C15H15NO
(225.29): calcd. C 79.97, H 6.71, N 6.22; found C 79.85, H 6.86, N
6.14.
P4B·Bu4Cl: 1H NMR (250 MHz, CD3OD): δ = 9.26 (s, 1 H,
CH=N), 7.73 (dd, J = 7.70, 1.69 Hz, 1 H, Ar), 7.49 (dd, J = 7.82,
1.56 Hz, 1 H, Ar), 7.03 (t, J = 7.76 Hz, 1 H, Ar), 4.07 (m, 2 H,
CH2), 3.72 (t, J = 5.98 Hz, 2 H, CH2), 3.18–3.26 (m + s, 17 H,
CH2 and NCH3), 1.86 (dq, J = 17.53, 7.65 Hz, 2 H, CH2), 1.66 (m,
8 H, CH2), 1.47 (s, 9 H, tBu), 1.37–1.46 (m, 8 H, CH2), 1.28 (dt, J
= 18.96, 7.61 Hz, 3 H, CH3), 1.03 (t, J = 7.28 Hz, 12 H, CH3) ppm.
13C NMR (75 MHz, CD3OD): δ = 166.67, 133.49, 131.45, 130.96,
126.60, 123.92, 118.24, 67.90, 59.57, 55.40, 54.77, 36.06, 31.44,
24.81, 24.31, 20.73, 13.95, 8.28 ppm. 31P NMR (122 MHz,
(m, 8 H, CH2), 1.50 (s, 9 H, tBu), 1.4–1.2 (m, 3 H, CH3), 1.03 (t, CD3OD): δ = 30.05 ppm. MS (ESI, MeOH): calcd. for [M + H]+
J = 14.5 Hz, 12 H, CH3) ppm. 13C NMR (63 MHz, CD3CN): δ =
191.68, 156.20 (d, JP,C = 9.3 Hz) 143.54 (d, JP,C = 3.7 Hz), 133.24,
132.34 (d, JP,C = 2.3 Hz), 125.83, 122.59 (d, JP,C = 1.2 Hz), 59.19,
35.79, 31.27, 24.20, 21.96, 20.23, 13.72, 8.76 (d, JP,C = 6.3 Hz) ppm.
31P NMR (122 MHz, CDCl3): δ = 26.79 ppm. MS (ESI; MeOH,
negative mode): m/z = 269.2 [M – H]+.
355.1, found 355.1. C18H31N2O3P (354.43): calcd. C 61.00, H 8.82,
N 7.90; found C 60.87, H 8.93, N 7.81.
P4C: 1H NMR (250 MHz, CD3OD): δ = 9.38 (s, 1 H, CH=N),
7.73 (dd, J = 1.6, J = 7.7 Hz, 1 H, Ar), 7.49 (dd, J = 1.2, J =
7.5 Hz, 1 H, Ar), 7.23–7.40 (m, 5 H, Ar), 7.02 (t, J = 7.8 Hz, 1 H,
Ar), 4.57 (s, 2 H, CH2Ar), 3.19–3.26 (m, 8 H, CH2), 1.8–1.6 (m, 10
H, CH2), 1.49 (s, 9 H, tBu), 1.5–1.3 (m, 8 H, CH2), 1.24 (td, J =
18.68, 7.65 Hz, 3 H, CH3), 1.02 (t, J = 7.28 Hz, 12 H, CH3) ppm.
13C NMR (63 MHz, CD3OD): δ = 165.43, 143.52, 140.84, 131.44,
130.95, 130.92, 129.92, 129.25, 127.97, 126.76, 123.98, 65.57, 59.56,
36.16, 31.59, 24.80, 24.16, 20.73, 13.94, 8.28 ppm. 31P NMR
(122 MHz, CD3OD): δ = 26.27 ppm. MS (ESI, MeOH, negative
mode): calcd. for [M]– 358.3, found 358.0. C36H61N2O3P (600.86):
calcd. C 71.96, H 10.23, N 4.66; found C 71.77, H 10.38, N 4.53.
General Procedure for the Synthesis of Imines P2B, P2C, P3B, P3C,
P4B, and P4C: Equivalent amounts of platform and amine were
dissolved in CD3OD (600 µL) in a screw-cap NMR tube to form a
5 m solution. The tube was kept at 50 °C for 2 d, and the reaction
monitored by NMR spectroscopy (disappearance of the aldehyde
proton signal). After cooling, the solvent was evaporated to give
the desired compound.
P2B·Bu4Cl: 1H NMR (250 MHz, CD3OD): δ = 8.92 (s, 1 H,
CH=N), 7.92 (dd, J = 7.79, 1.44 Hz, 1 H, Ar), 7.01–7.58 (m, 3 H,
Ar), 4.10 (m, 2 H, NCH2), 3.70 (t, J = 6.00 Hz, 2 H, NCH2), 3.19–
3.26 (m, 17 H, CH2 and NCH3), 1.59–1.83 (m, 10 H, CH2), 1.41
(m, 8 H, CH2), 1.21 (dt, J = 18.87, 7.97 Hz, 3 H, CH3), 1.02 (t, J
= 7.28 Hz, 12 H, CH3) ppm. 13C NMR (63 MHz, CD3OD): δ =
163.06, 133.49, 130.35, 127.85, 124.48, 123.37, 122.90, 67.84, 59.50,
55.79, 54.68, 30.75, 24.79, 20.73, 13.97, 8.26 ppm. 31P NMR
(122 MHz, CD3OD): δ = 26.36 ppm. MS (ESI; MeOH): calcd. for
[M + H]+ 299.2, found 299.1; calcd. for [M + Na]+ 321.2, found
321.1.
General Procedure for the Combinatorial Screening by Using Plat-
form P1
In the Absence of the Target Anion: A solution of amines A and B
([A] = [B] + 3[P1B3]) was added to a solution of imine P1B3 in
CD3OD (2 mL) to make the final concentrations reported in the
experiments. This solution was kept at 65 °C until full equilibration
of the library was observed as evidenced by the absence of changes
1
in the H NMR spectrum.
In the Presence of the Target Anion: A mother solution of imine
P1B3 in CD3OD (2 mL) was split into two portions. Amines A, B
([A] = [B] + 3[P1B3]), and the target anion were added to one of
the two to make twice the final concentrations of these additives
reported in the experiments. The two solutions were then mixed in
different ratios, and the resulting solution was kept at 65 °C until
full equilibration of the library was observed, as evidenced by the
P2C: 1H NMR (250 MHz, CD3OD): δ = 8.98 (s, 1 H, CH=N),
7.88 (dd, J = 7.80, 1.24 Hz, 1 H, Ar), 7.6–7.1 (m, 8 H, Ar), 4.55
(s, 2 H, CH2Ar), 3.3–3.2 (m, 8 H, CH2), 1.8–1.6 (m, 10 H, CH2),
1.41 (m, 8 H, CH2), 1.3–1.1 (m, 3 H, CH3), 1.02 (t, J = 7.26 Hz,
12 H, CH3) ppm. 13C NMR (63 MHz, CD3OD): δ = 161.78,
140.66, 136.71, 133.24, 129.60, 129.35, 128.25, 124.22, 123.20,
122.40, 118.23, 65.99, 59.50, 50.01, 24.79, 23.06, 20.77, 13.98,
8.28 ppm. 31P NMR (122 MHz, CD3OD): δ = 26.65 ppm. MS
(ESI, CD3OD, negative mode): calcd. for [M]– 302.2, found 301.9.
1
absence of changes in the H NMR spectrum.
General Procedure for the Combinatorial Screening by Using Plat-
forms P2–P4: The two amines B and C (5 equiv.) were added to a
5 m solution (600 µL) of the appropriate platform in CD3OD in
P3B: 1H NMR (250 MHz, CD3OD): δ = 8.87 (s, 1 H, CH=N), 7.87
(dd, J = 1.7, 7.7 Hz, 1 H, Ar), 7.46 (m, 1 H, Ar), 7.1–6.9 (m, 2 H,
Ar), 4.1–4.0 (m, 2 H, CH2), 3.89 (s, 3 H, OCH3), 3.67 (t, J = 5.3 Hz, an NMR tube, and the solution was kept at 50 °C until full equili-
2 H, CH2), 3.26 (s, 9 H, N, CH3) ppm. 13C NMR (63 MHz, bration of the library was observed, as evidenced by the absence of
1
CD3OD): δ = 162.05, 141.68, 134.21, 128.09, 125.00, 121.79, changes in the H NMR spectrum.
Eur. J. Org. Chem. 2010, 3858–3866
© 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
3865